These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29249016)

  • 21. Isolation of a new vinca alkaloid from the leaves of Ervatamia microphylla as an inhibitor of ras functions.
    Umezawa K; Ohse T; Yamamoto T; Koyano T; Takahashi Y
    Anticancer Res; 1994; 14(6B):2413-7. PubMed ID: 7872661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermal Proteome Profiling Reveals Glutathione Peroxidase 4 as the Target of the Autophagy Inducer Conophylline.
    Kakegawa J; Ohtsuka S; Yokoyama M; Hosoi T; Ozawa K; Hatanaka T
    Mol Pharmacol; 2021 Sep; 100(3):181-192. PubMed ID: 34127539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [THE USE OF REMAXOL IN THE TREATMENT OF METABOLIC SYNDROME IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND DIABETES MELLITUS 2 TYPE].
    Dudorenko SV; Kovalenko AL; Prokopenko SM; Belogurova EV
    Eksp Klin Gastroenterol; 2016; (6):89-94. PubMed ID: 30280846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design.
    Friedman S; Sanyal A; Goodman Z; Lefebvre E; Gottwald M; Fischer L; Ratziu V
    Contemp Clin Trials; 2016 Mar; 47():356-65. PubMed ID: 26944023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Combined Intervention with Germinated Vigna radiata and Aerobic Interval Training Protocol Is an Effective Strategy for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Other Alterations Related to the Metabolic Syndrome in Zucker Rats.
    Kapravelou G; Martínez R; Nebot E; López-Jurado M; Aranda P; Arrebola F; Cantarero S; Galisteo M; Porres JM
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28753963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of bioactive metabolites for pancreatic regeneration chemotherapy.
    Takatsuna H; Umezawa K
    Biomed Pharmacother; 2004 Dec; 58(10):610-3. PubMed ID: 15589071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
    Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-alcoholic fatty liver disease, as a component of the metabolic syndrome, and its causal correlations with other extrahepatic diseases].
    Halmos T; Suba I
    Orv Hetil; 2017 Dec; 158(52):2051-2061. PubMed ID: 29285942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asiatic acid mitigates hyperglycemia and reduces islet fibrosis in Goto-Kakizaki rat, a spontaneous type 2 diabetic animal model.
    Wang X; Lu Q; Yu DS; Chen YP; Shang J; Zhang LY; Sun HB; Liu J
    Chin J Nat Med; 2015 Jul; 13(7):529-34. PubMed ID: 26233843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model.
    Tzeng TF; Tzeng YC; Cheng YJ; Liou SS; Liu IM
    Nutrients; 2015 Oct; 7(10):8670-84. PubMed ID: 26506376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics, Tissue Distribution, Plasma Protein Binding Studies of 10-Dehydroxyl-12-Demethoxy-Conophylline, a Novel Anti-Tumor Candidate, in Rats.
    Jiang C; Li J; Cai X; Li N; Guo Y; Wang D
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30646543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats.
    Perry RJ; Zhang D; Zhang XM; Boyer JL; Shulman GI
    Science; 2015 Mar; 347(6227):1253-6. PubMed ID: 25721504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.
    Miyazaki T; Shirakami Y; Kubota M; Ideta T; Kochi T; Sakai H; Tanaka T; Moriwaki H; Shimizu M
    Oncotarget; 2016 Mar; 7(9):10448-58. PubMed ID: 26871288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
    Tsuneyama K; Nishida T; Baba H; Taira S; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Sutoh M; Oda E; Hokao R; Imura J
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1736-43. PubMed ID: 24730643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of resveratrol on experimental non-alcoholic steatohepatitis.
    Heebøll S; Thomsen KL; Clouston A; Sundelin EI; Radko Y; Christensen LP; Ramezani-Moghadam M; Kreutzfeldt M; Pedersen SB; Jessen N; Hebbard L; George J; Grønbæk H
    Pharmacol Res; 2015; 95-96():34-41. PubMed ID: 25814186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy.
    Ji G; Wang Y; Deng Y; Li X; Jiang Z
    Lipids Health Dis; 2015 Oct; 14():134. PubMed ID: 26498332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.
    Tan CC; Yu JT; Tan MS; Jiang T; Zhu XC; Tan L
    Neurobiol Aging; 2014 May; 35(5):941-57. PubMed ID: 24360503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.